Aula 15

Ocular oncology cases for retina specialists

Zelia M. Correa, MD. Ph.D. | Johns Hopkins Medicine
J. William Harbour, MD | Bascom Palmer Eye Institute

Zelia Maria Correa, M.D., Ph.D.

Médica no Johns Hopkings Hospital EUA
Professora de Oftalmologia, doutora pela UNIFESP, pós doc pela McGill University e Wills Eye Hospital EUA.
Especialista em retina, vítreo e oncologia Ocular.

Titles

The Tom Clancy Endowed Professor of Ophthalmology
Professor of Ophthalmology
Professor of Oncology

Dr. Zélia Correa is a Professor of Ophthalmology at the Wilmer Eye Institute. She specializes in intraocular and conjunctival tumors with particular interest in ocular melanoma, retinoblastoma, ocular metastasis, and conjunctival melanomas. She has been recognized for her research in the field of ocular oncology and is part of the steering committee of the Collaborative Ocular Oncology Group, currently the largest NIH funded prospective study in Uveal Melanoma. She is the Director of the Echography Service at the Wilmer Eye Institute. Her clinical interests also include radiation therapy to the eye, vitreoretinal diseases and surgery, fine needle aspiration biopsy of ocular tumors, retinal detachment and ophthalmology.

Education

Degrees

MD, Faculdade de Medicina de Sao Jose do Rio Preto (1989)

Residencies

Faculdade de Medicina de Marilia (Marilia Medical School) / Ophthalmology (1992)

Fellowships

McGill University School of Medicine (2004)
Thomas Jefferson University Hospital (2004)

Board Certifications

Foreign Boards / Ophthalmology

J. William Harbour, M.D.

Director of Ocular Oncology, Vice Chairman for Translational Research, Mark J. Daily Chair in Ophthalmology, and Associate Director for Basic Research at Sylvester Comprehensive Cancer Center.

The Ocular Oncology Laboratory, directed by Dr. Harbour, focuses on the identification of genetic, epigenetic and genomic abnormalities that lead to poor patient outcome in uveal melanoma, retinoblastoma and other eye cancers, with the goal of developing more accurate prognostic biomarkers and targeted molecular therapies that will lead to improved survival.

Education:

B.S. at Texas A&M University, College Station, TX.
M.D. at Johns Hopkins University School of Medicine, Baltimore, MD.
Ophthalmology Residency at Wills Eye Hospital, Philadelphia, PA.
Vitreoretinal Disease and Surgery Fellowship at Bascom Palmer Eye Institute, Miami, FL.
Ocular Oncology Fellowship at University of California, San Francisco, CA.
Research Fellowship at National Institutes of Health, Bethesda, MD.
Research Fellowship at Division of Molecular Oncology, Washington University St. Louis, MO